Search results for: Pharmaceutical Industry
Filter search results
The Use of Pay-for-Performance for Drugs: Can It Improve Incentives for Innovation?
1 February 2012
…rather than merely “paying for pills”. Despite its intuitive appeal, this approach is highly controversial and is disliked by many health care providers, policy makers, and pharmaceutical companies. In this…
Hospital Purchasing
1 September 1972
…of medical and non-medical goods purchased, from boiler fuel to pharmaceuticals and from food to surgical instruments. Nor do they give any impression of the range of needs which have…
New Drugs to Tackle Antimicrobial Resistance: EU Policy Options
1 October 2010
…been de-emphasised by biopharmaceutical companies. Four key sets of factors are identified that provide serious disincentives for R&D. The authors develop a model to assess the push, pull and hybrid…
Forward Together: Complementarity of Public and Charitable Research with Respect to Private Research Spending
9 January 2009
…may be particularly important in the pharmaceutical and biotech sectors because of the characteristics of that R&D, including high uncertainty, high rates of failure and high costs. The study reports…
The Market for Biosimilars: Evolution and Policy Options
1 November 2008
…deter biosimilar entry and reduce long term savings. Outcomes data also are important in helping assess the value for money of second generation biopharmaceutical products as compared to the first…
Vaccination
1 September 1974
…sources of many infections have been eliminated and the resistance of the population to communicable illness has been raised. Pharmaceutical developments since the 1930s have also aided in the reduction…
Brand Names in Prescribing
1 September 1976
…bioavailability problems can be predicted from the nature of the drug or of the formulation. Politicians who stress only comparative prices of pharmaceutical products to gain political advantage do so…
Hannah Hussain
4 September 2024
…the General Pharmaceutical Council (GPhC), she has prior experience working in NHS primary care settings. Before joining OHE, Hannah worked as a research associate at the Manchester Centre for Health…
Crisis in Research
1 April 1986
…general and then focuses on the specific issues that confront medicine. In the latter context the problems which beset the Medical Research Council and pharmaceutical research are considered in detail….